Trial Profile
A study investigating the effect of boceprevir given with peginterferon alpha-2b/ribavirin and association between sustained virologic response and baseline viral load in patients with chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 11 Dec 2015 New trial record